Cargando…

Effectiveness of VISIA system in evaluating the severity of rosacea

BACKGROUND: Rosacea is a facial chronic inflammatory skin disease with almost 5.5% prevalence. Although there are various scales of rosacea, they are objective and discordant among different dermatologists. Noninvasive objective measurements such as VISIA system might play essential roles in the dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yu, Jia, Kaiyu, Yan, Sihan, Jiang, Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907647/
https://www.ncbi.nlm.nih.gov/pubmed/35818722
http://dx.doi.org/10.1111/srt.13194
_version_ 1784884213246328832
author Pan, Yu
Jia, Kaiyu
Yan, Sihan
Jiang, Xian
author_facet Pan, Yu
Jia, Kaiyu
Yan, Sihan
Jiang, Xian
author_sort Pan, Yu
collection PubMed
description BACKGROUND: Rosacea is a facial chronic inflammatory skin disease with almost 5.5% prevalence. Although there are various scales of rosacea, they are objective and discordant among different dermatologists. Noninvasive objective measurements such as VISIA system might play essential roles in the diagnosis and evaluation of rosacea. Here, we intended to reveal the effectiveness of VISIA system in rosacea. MATERIALS AND METHODS: A number of 563 participants diagnosed with facial rosacea were enrolled in study. They all received both full‐face image‐shoot by VISIA system with quantitative analysis software and physician's assessment via five different scales, including investigator global assessment (IGA), clinician erythema assessment (CEA), numerical score, the National Rosacea Society (NRS) grading system and telangiectasis. RESULTS: Absolute score and percentile of red area had significant correlations with IGA and CEA, whereas red area had no significant correlation with numerical score, NRS and telangiectasis. Red area in erythematotelangiectatic rosacea patients demonstrated the highest correlation with IGA and CEA, especially in those aged between 51 and 60. Besides red area, pigmentation parameters in VISIA system (brown spot) also showed significant correlation with IGA and CEA. CONCLUSION: VISIA system might be an effective measurement in the assessment of rosacea severity.
format Online
Article
Text
id pubmed-9907647
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99076472023-04-13 Effectiveness of VISIA system in evaluating the severity of rosacea Pan, Yu Jia, Kaiyu Yan, Sihan Jiang, Xian Skin Res Technol Original Articles BACKGROUND: Rosacea is a facial chronic inflammatory skin disease with almost 5.5% prevalence. Although there are various scales of rosacea, they are objective and discordant among different dermatologists. Noninvasive objective measurements such as VISIA system might play essential roles in the diagnosis and evaluation of rosacea. Here, we intended to reveal the effectiveness of VISIA system in rosacea. MATERIALS AND METHODS: A number of 563 participants diagnosed with facial rosacea were enrolled in study. They all received both full‐face image‐shoot by VISIA system with quantitative analysis software and physician's assessment via five different scales, including investigator global assessment (IGA), clinician erythema assessment (CEA), numerical score, the National Rosacea Society (NRS) grading system and telangiectasis. RESULTS: Absolute score and percentile of red area had significant correlations with IGA and CEA, whereas red area had no significant correlation with numerical score, NRS and telangiectasis. Red area in erythematotelangiectatic rosacea patients demonstrated the highest correlation with IGA and CEA, especially in those aged between 51 and 60. Besides red area, pigmentation parameters in VISIA system (brown spot) also showed significant correlation with IGA and CEA. CONCLUSION: VISIA system might be an effective measurement in the assessment of rosacea severity. John Wiley and Sons Inc. 2022-07-11 /pmc/articles/PMC9907647/ /pubmed/35818722 http://dx.doi.org/10.1111/srt.13194 Text en © 2022 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Pan, Yu
Jia, Kaiyu
Yan, Sihan
Jiang, Xian
Effectiveness of VISIA system in evaluating the severity of rosacea
title Effectiveness of VISIA system in evaluating the severity of rosacea
title_full Effectiveness of VISIA system in evaluating the severity of rosacea
title_fullStr Effectiveness of VISIA system in evaluating the severity of rosacea
title_full_unstemmed Effectiveness of VISIA system in evaluating the severity of rosacea
title_short Effectiveness of VISIA system in evaluating the severity of rosacea
title_sort effectiveness of visia system in evaluating the severity of rosacea
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907647/
https://www.ncbi.nlm.nih.gov/pubmed/35818722
http://dx.doi.org/10.1111/srt.13194
work_keys_str_mv AT panyu effectivenessofvisiasysteminevaluatingtheseverityofrosacea
AT jiakaiyu effectivenessofvisiasysteminevaluatingtheseverityofrosacea
AT yansihan effectivenessofvisiasysteminevaluatingtheseverityofrosacea
AT jiangxian effectivenessofvisiasysteminevaluatingtheseverityofrosacea